Literature DB >> 18362922

TAT opens the door.

Piyush M Vyas1, Ronald M Payne.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18362922      PMCID: PMC2989497          DOI: 10.1038/mt.2008.24

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  21 in total

1.  Targeting proteins to mitochondria using TAT.

Authors:  Victoria Del Gaizo; James A MacKenzie; R Mark Payne
Journal:  Mol Genet Metab       Date:  2003 Sep-Oct       Impact factor: 4.797

Review 2.  TAT-mediated protein transduction: delivering biologically active proteins to the heart.

Authors:  Asa B Gustafsson; Roberta A Gottlieb; David J Granville
Journal:  Methods Mol Med       Date:  2005

3.  Molecular basis of lipoamide dehydrogenase deficiency in Ashkenazi Jews.

Authors:  A Shaag; A Saada; I Berger; H Mandel; A Joseph; A Feigenbaum; O N Elpeleg
Journal:  Am J Med Genet       Date:  1999-01-15

Review 4.  The blood-brain barrier: principles for targeting peptides and drugs to the central nervous system.

Authors:  D J Begley
Journal:  J Pharm Pharmacol       Date:  1996-02       Impact factor: 3.765

5.  Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability.

Authors:  V A Levin
Journal:  J Med Chem       Date:  1980-06       Impact factor: 7.446

6.  In vivo protein transduction: delivery of a biologically active protein into the mouse.

Authors:  S R Schwarze; A Ho; A Vocero-Akbani; S F Dowdy
Journal:  Science       Date:  1999-09-03       Impact factor: 47.728

7.  Crystal structure of human dihydrolipoamide dehydrogenase: NAD+/NADH binding and the structural basis of disease-causing mutations.

Authors:  Chad A Brautigam; Jacinta L Chuang; Diana R Tomchick; Mischa Machius; David T Chuang
Journal:  J Mol Biol       Date:  2005-07-15       Impact factor: 5.469

Review 8.  Mitochondrial diseases in man and mouse.

Authors:  D C Wallace
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

9.  The cellular uptake of horseradish peroxidase and its poly(lysine) conjugate by cultured fibroblasts is qualitatively similar despite a 900-fold difference in rate.

Authors:  H J Ryser; I Drummond; W C Shen
Journal:  J Cell Physiol       Date:  1982-10       Impact factor: 6.384

10.  Unfolding of preproteins upon import into mitochondria.

Authors:  B Gaume; C Klaus; C Ungermann; B Guiard; W Neupert; M Brunner
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

View more
  7 in total

1.  Cardiomyopathy of Friedreich's ataxia: use of mouse models to understand human disease and guide therapeutic development.

Authors:  R Mark Payne; P Melanie Pride; Clifford M Babbey
Journal:  Pediatr Cardiol       Date:  2011-03-01       Impact factor: 1.655

Review 2.  Transduction of human recombinant proteins into mitochondria as a protein therapeutic approach for mitochondrial disorders.

Authors:  Lefkothea C Papadopoulou; Asterios S Tsiftsoglou
Journal:  Pharm Res       Date:  2011-08-27       Impact factor: 4.200

3.  Import of TAT-Conjugated Propionyl Coenzyme A Carboxylase Using Models of Propionic Acidemia.

Authors:  Renata Collard; Tomas Majtan; Insun Park; Jan P Kraus
Journal:  Mol Cell Biol       Date:  2018-02-27       Impact factor: 4.272

4.  Replacement of the C6ORF66 assembly factor (NDUFAF4) restores complex I activity in patient cells.

Authors:  Dana Marcus; Michal Lichtenstein; Ann Saada; Haya Lorberboum-Galski
Journal:  Mol Med       Date:  2013-07-24       Impact factor: 6.354

Review 5.  CPP-ZFN: a potential DNA-targeting anti-malarial drug.

Authors:  Vikrant Nain; Shakti Sahi; Anju Verma
Journal:  Malar J       Date:  2010-09-16       Impact factor: 2.979

6.  Targeted genome engineering in human induced pluripotent stem cells by penetrating TALENs.

Authors:  Renli Ru; Yongchao Yao; Songlin Yu; Benpeng Yin; Wanwan Xu; Siting Zhao; Li Qin; Xiaoping Chen
Journal:  Cell Regen (Lond)       Date:  2013-06-18

7.  Cell-penetrating artificial mitochondria-targeting peptide-conjugated metallothionein 1A alleviates mitochondrial damage in Parkinson's disease models.

Authors:  Young Cheol Kang; Minuk Son; Sora Kang; Suyeol Im; Ying Piao; Kwang Suk Lim; Min-Young Song; Kang-Sik Park; Yong-Hee Kim; Youngmi Kim Pak
Journal:  Exp Mol Med       Date:  2018-08-17       Impact factor: 8.718

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.